Antipsychotic Drug Action, Novel Treatment Targets, and the Failure of Current Clinical Trial Designs in Evaluating New Target Molecules

Biological Psychiatry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles